During the past decade, Valley Cancer Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Valley Cancer Associates" #1 collaborator was "Kyowa Kirin, Inc." with 1 trials as a collaborator and "Roche-Genentech" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Valley Cancer Associates" are "Follicular Lymphoma (FL)" (1 trials), "KRAS p, G12c Mutated /Advanced Metastatic NSCLC" (1 trials), "Marginal Zone Lymphoma" (1 trials), "Metastatic Pancreatic Adenocarcinoma" (1 trials) and "Non Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Valley Cancer Associates" in a lesser frequency.

Most popular intervention types in "Valley Cancer Associates" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "AMG 510" (1 trials), "Atezolizumab" (1 trials), "Bendamustine" (1 trials), "CHOP" (1 trials) and "CO-1.01" (1 trials). Other intervention names were less common.

The vast majority of trials in "Valley Cancer Associates" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Valley Cancer Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Valley Cancer Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Valley Cancer Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".